Back to Search Start Over

Dynamics of respiratory symptoms during infancy and associations with wheezing at school age.

Authors :
Usemann J
Xu B
Delgado-Eckert E
Korten I
Anagnostopoulou P
Gorlanova O
Kuehni C
Röösli M
Latzin P
Frey U
Source :
ERJ open research [ERJ Open Res] 2018 Nov 20; Vol. 4 (4). Date of Electronic Publication: 2018 Nov 20 (Print Publication: 2018).
Publication Year :
2018

Abstract

Children with frequent respiratory symptoms in infancy have an increased risk for later wheezing, but the association with symptom dynamics is unknown. We developed an observer-independent method to characterise symptom dynamics and tested their association with subsequent respiratory morbidity. In this birth-cohort of healthy neonates, we prospectively assessed weekly respiratory symptoms during infancy, resulting in a time series of 52 symptom scores. For each infant, we calculated the transition probability between two consecutive symptom scores. We used these transition probabilities to construct a Markov matrix, which characterised symptom dynamics quantitatively using an entropy parameter. Using this parameter, we determined phenotypes by hierarchical clustering. We then studied the association between phenotypes and wheezing at 6 years. In 322 children with complete data for symptom scores during infancy (16 864 observations), we identified three dynamic phenotypes. Compared to the low-risk phenotype, the high-risk phenotype, defined by the highest entropy parameter, was associated with an increased risk of wheezing (odds ratio (OR) 3.01, 95% CI 1.15-7.88) at 6 years. In this phenotype, infants were more often male (64%) and had been exposed to environmental tobacco smoke (31%). In addition, more infants had siblings (67%) and attended childcare (38%). We describe a novel method to objectively characterise dynamics of respiratory symptoms in infancy, which helps identify abnormal clinical susceptibility and recovery patterns of infant airways associated with persistent wheezing.<br />Competing Interests: Conflict of interest: P. Latzin reports receiving personal fees from Vertex, Novartis, Roche, Polyphor, Vifor and Gilead outside the submitted work.

Details

Language :
English
ISSN :
2312-0541
Volume :
4
Issue :
4
Database :
MEDLINE
Journal :
ERJ open research
Publication Type :
Academic Journal
Accession number :
30474038
Full Text :
https://doi.org/10.1183/23120541.00037-2018